Coke takes anti-obesity campaign global
(AP)—Coca-Cola says it will work to make lower-calorie drinks and clear nutrition information more widely available around the world, intensifying a push against critics who say its drinks pack on the pounds.
Overweight and Obesity
May 08, 2013 |
not rated yet |
0
India's rejection of drug patent could reverberate
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. ...
Medications
Apr 01, 2013 |
not rated yet |
0
Bayer profits up 11.5 percent on new drugs
German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.
Medications
Apr 25, 2013 |
not rated yet |
0
US court orders wider access for morning-after pill (Update 2)
After a decade-long battle over access to emergency contraception, a federal judge ordered US regulators Friday to make the morning-after pill available over the counter without age limits.
Medications
Apr 05, 2013 |
not rated yet |
0
Novartis posts profit gain thanks to new drugs (Update)
(AP)—Swiss pharmaceutical company Novartis AG reported a 6.7 percent increase in profit for the first quarter Wednesday, boosted by new products and emerging markets.
Medications
Apr 24, 2013 |
not rated yet |
0
Drugs firm GSK eyes India acquisitions: chief executive
British drugmaker GlaxoSmithKline is in the market to buy assets in India at a total cost of up to $2.0 billion (1.5 billion euros), its chief executive said in an interview published on Monday.
Medications
Oct 03, 2011 |
not rated yet |
0
US drug firm Mylan to buy Indian firm for $1.6 bn
US generic drugs specialist Mylan said Thursday it would buy a unit of India's pharma firm Strides Arcolab for $1.6 billion, boosting its presence in the high-growth injectable drugs market.
Medications
Feb 27, 2013 |
not rated yet |
0
GlaxoSmithKline says Q3 net profits drop 18.5%
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profits fell 18.5 percent from a year earlier to £1.12 billion ($1.80 billion, 1.39 billion euros), hit by weak conditions in Europe.
Other
Nov 01, 2012 |
not rated yet |
0
US Pfizer, India's Biocon scrap insulin pact
India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.
Medications
Mar 13, 2012 |
not rated yet |
0
Pfizer 3Q profit falls 14 pct on generic Lipitor (Update)
(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Other
Nov 01, 2012 |
not rated yet |
0
